Hui Dai

Hui Dai

Auto-generated profile, based on publicly available information

Hui Dai

Department of System Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
DMDaniel McGrail
Daniel McGrail
PPPatrick G. Pilié
Patrick G. Pilié
HDHui Dai
Hui Dai
TLTruong Nguyen Anh Lam
Truong Nguyen Anh Lam
YLYulong Liang
Yulong Liang
SLShiaw-Yih Lin
Shiaw-Yih Lin
Endogenous and induced replication stress response defects promote tumor immunogenicity via generation of cytosolic single-stranded DNA.

31 May 2023 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
LSLuana Guimaraes Sousa
Luana Guimaraes Sousa
DMDaniel McGrail
Daniel McGrail
FNFelippe Lazar Neto
Felippe Lazar Neto
KLKaiyi Li
Kaiyi Li
MMMario L. Marques-Piubelli
Mario L. Marques-Piubelli
RFRenata Ferrarotto
Renata Ferrarotto
Purpose: Adenoid cystic carcinoma (ACC) is a heterogeneous malignancy, and no effective systemic therapy exists for metastatic disease. We previously described two prognostic ACC molecular subtypes with distinct therapeutic vulnerabilities, ACC-I and ACC-II. In this study, we explored the ACC tumor microenvironment (TME) using RNA-sequencing and spatial biology to identify potential therapeutic targets. Experimental Design: Tumor samples from 62 ACC patients with available RNA-sequencing data that had been collected as part of previous studies were stained with a panel of 28 validated metal-tagged antibodies. Imaging mass cytometry (IMC) was performed using the Fluidigm Helios CyTOF instrument and analyzed with Visiopharm software. The B7-H4 antibody–drug conjugate AZD8205 was tested in ACC patient-derived xenografts (PDX). Results: RNA deconvolution revealed that most ACCs are immunologically “cold,” with approximately 30% being “hot.” ACC-I tumors with a poor prognosis harbored a higher density of immune cells; however, spatial analysis by IMC revealed that ACC-I immune cells were significantly restricted to the stroma, characterizing an immune-excluded TME. ACC-I tumors overexpressed the immune checkpoint B7-H4, and the degree of immune exclusion was directly correlated with B7-H4 expression levels, an independent predictor of poor survival. Two ACC-I/B7-H4-high PDXs obtained 90% complete responses to a single dose of AZD8205, but none were observed with isotype-conjugated payload or in an ACC-II/B7-H4 low PDX. Conclusions: Spatial analysis revealed that ACC subtypes have distinct TMEs, with enrichment of ACC-I immune cells that are restricted to the stroma. B7-H4 is highly expressed in poor-prognosis ACC-I subtype and is a potential therapeutic target.

15 August 2023
Verified
Other
Open access
LSLuana Guimaraes Sousa
Luana Guimaraes Sousa
DMDaniel McGrail
Daniel McGrail
FNFelippe Lazar Neto
Felippe Lazar Neto
KLKaiyi Li
Kaiyi Li
MMMario L. Marques-Piubelli
Mario L. Marques-Piubelli
RFRenata Ferrarotto
Renata Ferrarotto
Supplementary material including methods, supplementary table 1, supplementary table 2, and supplementary table 3

12 July 2023
Verified
Other
Open access
LSLuana Guimaraes Sousa
Luana Guimaraes Sousa
DMDaniel McGrail
Daniel McGrail
FNFelippe Lazar Neto
Felippe Lazar Neto
KLKaiyi Li
Kaiyi Li
MMMario L. Marques-Piubelli
Mario L. Marques-Piubelli
RFRenata Ferrarotto
Renata Ferrarotto
Supplementary Figures 1 from Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors

16 September 2024
Verified
Other
Open access
LSLuana G. de Sousa
Luana G. de Sousa
DMDaniel McGrail
Daniel McGrail
FNFelippe Lazar Neto
Felippe Lazar Neto
KLKaiyi Li
Kaiyi Li
MMMario L. Marques-Piubelli
Mario L. Marques-Piubelli
RFRenata Ferrarotto
Renata Ferrarotto
Supplementary material including methods, supplementary table 1, supplementary table 2, and supplementary table 3

16 September 2024
Verified
Other
Open access
LSLuana G. de Sousa
Luana G. de Sousa
DMDaniel McGrail
Daniel McGrail
FNFelippe Lazar Neto
Felippe Lazar Neto
KLKaiyi Li
Kaiyi Li
MMMario L. Marques-Piubelli
Mario L. Marques-Piubelli
RFRenata Ferrarotto
Renata Ferrarotto
Supplementary material including methods, supplementary table 1, supplementary table 2, and supplementary table 3